Abstract
CD8+ T cells are perceived to play a major role in the pathogenesis of type 1 diabetes (T1D). In this study, we characterized the function and phenotype of circulating CD8+ memory T cells in samples from individuals at different stages of T1D progression using flow cytometry and single-cell multiomics. We observed two distinct CD8+ T-cell signatures during progression of T1D within the highly differentiated CD272CD8+ memory T-cell subset. A proinflammatory signature, with an increased frequency of IFN-g+TNF-a+ CD272CD8+ memory T cells, was observed in children with newly diagnosed T1D (stage 3) and correlated with the level of dysglycemia at diagnosis. In contrast, a coinhibitory signature, with an increased frequency of KLRG1+TIGIT+ CD272CD8+ memory T cells, was observed in islet autoantibody-positive children who later progressed to T1D (stage 1). No alterations within CD272CD8+ memory T cells were observed in adults with established T1D or in children during the initial seroconversion to islet autoantibody positivity. Single-cell multiomics analyses suggested that CD272CD8+ T cells expressing the IFNG1TNF1 proinflammatory signature may be distinct from those expressing the KLRG11TIGIT1 coinhibitory signature at the single-cell level. Collectively, our findings suggest that distinct blood CD8+ T-cell signatures could be employed as potential biomarkers of T1D progression.
Original language | English |
---|---|
Pages (from-to) | 1705-1715 |
Number of pages | 11 |
Journal | Diabetes |
Volume | 73 |
Issue number | 10 |
DOIs | |
Publication status | Published - 2024 |
Publication type | A1 Journal article-refereed |
Publication forum classification
- Publication forum level 3
ASJC Scopus subject areas
- Internal Medicine
- Endocrinology, Diabetes and Metabolism